๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials India
Clinical trial register · India

Studies with an Indian investigative site

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1126 matching records held by the registry are in this view. Synced 23 Sep 2026, 03:16 UTC
1126
Studies in scope
all four open statuses
611
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 334 Mumbai 258 Hyderabad 237 Bangalore 195 Pune 189
Narrow the register
Recruitment status
Phase
Site location
New Delhi334 Mumbai258 Hyderabad237 Bangalore195 Pune189
All 273 locations
Target enrolment
to
1126 of 1126 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Active, closed
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)
NCT02542293Non Small Cell Lung Carcinoma NSCLC
AstraZeneca
Phase 3
953
Ahmedabad, Bangalore, Chennai, Gurgaon, Karamsad, New Delhi
2015-11-03
Active, closed
A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
NCT03127631Prostate Cancer, Cardiovascular Disease
McMaster University
Not applicable
5,000
Sฤซtฤpura, Bengaluru, Bangalore, Hyderabad
2015-10-21
Active, closed
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
NCT02365597Urothelial Cancer
Janssen Research & Development, LLC
Phase 2
239
Bangalore, Kolkata, Mira Road (East), Nadiฤd
2015-04-22
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
Novartis Pharmaceuticals
Phase 4
279
Pune
2015-03-05
Active, closed
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
NCT02227251Diffuse Large B-cell Lymphoma
Karyopharm Therapeutics Inc
Phase 2
244
Patna, Vadapalani, Delhi, Thiruvananthapuram, Mumbai, Pune, New Delhi, Bhubaneswar
2014-11
Active, closed
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
NCT02138734Non-muscle Invasive Bladder Cancer
ImmunityBio, Inc.
Phase 1/2
369
Visakhapatnam, Adyฤr, Ahmedabad, Aurangabad, Nagpur, Pune, Mumbai, New Delhi
2014-07-21
Recruiting
Pre Operative Trastuzumab in Operable Breast Cancer
NCT01785420Carcinoma Breast Stage I, HER2 Positive Breast Cancer
Dr Rajendra A. Badwe
Phase 3
1,100
Mumbai
2013-05
Active, closed
Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection
NCT01651403Chronic Hepatitis B
Gilead Sciences
Phase 3
90
Surat, Gurgaon, Nagpur, Jaipur, Lucknow, Bangalore
2012-12-06
Active, closed
Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer
NCT01566240Cervical Cancer
University College, London
Phase 3
500
Kolkata
2012-11-08
By invitation
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvรฉ-Perthes Disease
NCT02040714Legg Calve Perthes Disease
Texas Scottish Rite Hospital for Children
Observational
1,500
Udupi
2012-08
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Jaipur, Hyderabad, Bangalore, Bengaluru, Chennai, Gurgaon, Kochi, New Delhi
2012-01
Active, closed
Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer
NCT01916317Operable Breast Cancer
Tata Memorial Hospital
Phase 3
1,600
Guwahati, Ahmedabad, Kannur, Kolhฤpur, Mumbai, Pune, Sangli, Shillong
2011-12-12
Active, closed
Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer
NCT02302105Prostate Cancer
Tata Memorial Centre
Not applicable
224
Navi Mumbai
2011-11-25
Active, closed
Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer
NCT02161900Non Metastatic Operable Breast Cancer
Tata Memorial Hospital
Not applicable
850
Mumbai
2010-11-12
Recruiting
Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis
NCT01212250Cirrhosis
Institute of Liver and Biliary Sciences, India
Not applicable
132
New Delhi
2010-09-01
Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
NCT02493478Failed or Difficult Intubation, Sequela, Intubation; Difficult, Intubation Complication
Children's Hospital of Philadelphia
Observational
150,000
Bengaluru, Bangalore
2010-03
Recruiting
Vicente Ferrer HIV Cohort Study
NCT02454569HIV, Tuberculosis, Cryptococcosis, Opportunistic Infections
Rural Development Trust Hospital
Observational
30,000
Battalapalli
2009-09
Recruiting
Maternal Newborn Health Registry
NCT01073475Pregnancy Outcome Trends in Low-resource Geographic Areas
NICHD Global Network for Women's and Children's Health
Observational
950,000
Nagpur, Belagavi
2008-05
Active, closed
Comparison of Fulvestrant (FASLODEXโ„ข) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
NCT00099437Breast Cancer
AstraZeneca
Phase 3
736
Ansฤrinagar, Bhopal, Hyderabad, Jaipur, Kolkata, Manipal, Marg Jaipur, Mumbai
2005-02-13
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Ahmedabad, Kolkata, Secunderabad, Vellore
2004-09-15
Recruiting
Prospective Urban Rural Epidemiology Study
NCT03225586Cardiovascular Diseases, Risk Factor, Cardiovascular, Health Behavior, Environmental Exposure
Population Health Research Institute
Observational
200,000
Bangalore, Thiruvananthapuram, Jaipur, Chennai, Chandigarh
2002-01-01
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
NCT00196742Fabry Disease
Genzyme, a Sanofi Company
Observational
9,000
Ahmedabad, Kolkata, Secunderabad, Vellore
2001-07-31
Active, closed
FA Clinical Outcome Measures
NCT03090789Friedreich Ataxia, Neuro-Degenerative Disease
Friedreich's Ataxia Research Alliance
Observational
2,000
New Delhi
2001-01-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Ahmedabad, Jaipur, Kolkata, Mumbai, Secunderabad, Vellore
1991-04-01
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia
Medtronic
Observational
20,000
Bangalore, Chennai, Gurgaon, Hyderabad, Jaipur, Kochi, New Delhi
1983-01
Rows per page Showing 1101–1126 of 1126
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-india?page=12

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

Browse trials by condition

Breast Cancer (19) Obesity (16) Heart Failure (14) Carcinoma, Non-Small-Cell Lung (14) Overweight (13) Cervical Cancer (12) Non-Small Cell Lung Cancer (11) Liver Cirrhosis (10) Chronic Kidney Disease (9) Diabetes Mellitus, Type 2 (9) Ulcerative Colitis (8) Coronary Artery Disease (8) Periodontitis (7) Schizophrenia (7) Multiple Myeloma (7)

Browse trials by site location

New Delhi (334) Mumbai (258) Hyderabad (237) Bangalore (195) Pune (189) Kolkata (166) Ahmedabad (157) Nagpur (123) Jaipur (104) Chandigarh (104) Nashik (99) Delhi (97) Belagavi (91) Chennai (88) Surat (86)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.